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This report describes the basic structural and bio- 
synthetic features of Mo5, a novel plasma mem- 
brane differentiation antigen (Ag) of the human 
myeloid lineage. As defined by the binding of anti- 
Mo5 monoclonal antibody (mAb), this Ag is ex- 
pressed by virtually all myeloperoxidase-positive 
myeloid precursors beyond the CFU-GM in hu- 
man bone marrow and is retained by circulating 
monocytes and polymorphonuclear neutrophils 
(PMNs) (1). Other hematopoietic elements of 
blood and bone marrow are Mo5-negative (1). 
Among myeloid cell lines, the monocytoid U-937 
(2) and THP-I (3) lines are Mo5-positive, while 
HL-60 (4) and KG-I (5) are essentially negative 
(1). Mo5 expression by these myeloid lines (either 
positive or negative) exhibits no significant change 
as a result of their exposure to soluble stimuli 
inducing monocytic differentiation, which is in 
contrast to the acquired expression of Mol 
(CDI lbICDI8) under the same conditions (1). 
Among leukemic cells of myeloid and lymphoid 
origin, Mo5 expression is restricted to acute myelo- 
genous leukemia (FAB grp. M4, M5 > M1-3), pro- 
viding an additional laboratory feature to distin- 
guish the malignant cells of this lineage (6).  
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The surface expression of hi05 by PMNs has 
been shown to be modulated by factors that in- 
clude degranulating stimuli, which produce a three- 
fold increase in the number of antigenic sites, and 
anti-Mo5 mAb which induces antigenic down- 
modulation with the reversible loss of Mo5 ex- 
pression (1). Although monocytes demonstrate a 
similar down-modulation of MoS surface ex- 
pression after exposure to anti-Mo5 mAb, no anal- 
ogous up-modulation of surface Mo5 by activating 
stimuli (e.g., PMA) has been demonstrated (1). 
Thus, Mo5 represents a unique myelomonmytic 
differentiation Ag whose surface expression is ind- 
ucibly altered depending on the cell type and nature 
of the stimulus. To extend our characterization of 
the Mo5 Ag, we have pursued a series of immuno- 
precipitation experiments which serve to define its 
basic structural and biosynthetic features. 
The anti-Mo5 mAb (clone 99, IgG2a) was puri- 
fied from ascites by column chromatography using 
protein A-Sepharose (CL4B, Pharmacia, Uppsala, 
Sweden) (7). Anti-Mo5-protein A-Sepharose con- 
jugate was prepared according to the method of 
Schneider et al. (8). Control conjugates were made 
according to the same protocol using anti-Mol (9) 
and anti-BMM1 (10) mAb. Ag immunoprecipita- 
tion was accomplished by adding 10 p1 aliquots 
of prewashed, packed mAb-protein A-Sepharose 
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conjugates to 150-200 p1 of precleared radiolabeled 
lysate and tumbled at room temperature for 2 h 
(1 1). The immunoadsorbed conjugates were 
washed 4 times with 10 mM Tris-HC1, pH 8.6,0.1% 
SDS, 0.05% NP-40, 300 mM NaCl. The washed 
conjugate pellets were eluted by boiling at 100°C 
for 5 min under either reducing or non-reducing 
conditions and subjected to SDS-PAGE (12). 
As shown in Fig. 1, M05 appeared as a single 
band of 50 kD on SDS-PAGE after immunoprecip- 
itation of Ag from W-40 lysates of ‘zI-labeled (1 3) 
U-937 cells (Fig. 1; lane 1; U-937, non-reducing not 
shown) and as a somewhat mores heterogeneous 
species of similar m.w. from FMLP-stimulated 
PMNs (14, 15) (Fig. 1; lanes 3, 5). In both cell 
types, the electrophoretic mobility of Mo5 was un- 
altered by reducing conditions suggesting the ab- 
sence of intrachain disulfide bonds (U-937, non- 
reducing; data not shown). ’H-labeling of surface 
glycan residues (16) using sodium borohydride 
INaB(3H),] produced identical results (Fig. 1; lanes 
7, 9), indicating that Mo5 is a glycoprotein Ag. 
To assess the nature and extent of glycosylation 
of the surface molecule, glycosidase digestion (17) 
of the immunoprecipitated Mo5 Ag on U-937 cells 
and FMLP-stimulated PMNs was performed. As 
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Figure I. Composite SDS-PAGE of Mo5 imrnunoprecipitated 
from NP-40 lysates of surface radiolabeled U-937 cells (U) and 
FMLP-stimulated PMNs (P) under reducing (R) and nonreduc- 
ing (NR) conditions (Li-937, nonreducing; not shown). Un- 
stimulated U-937 cells and PMNs exposed to 1 pM FMLP for 
15 min were surface labeled with ‘ = I  or NaB’H,, and lysed in 
NP-40-containing buffer. Mo5 Ag was imrnunoprecipitated 
from preclearcd NP-40 lysates. eluted in sample buffer in the 
presence (reducing) or absence (nonreducing) of 2-ME and 
subjected to SDS-PAGE ( ~ W O  acrylamide). Even-numbered 
lanes represent isotype-identical control (C) immunoprecipita- 
tes (IgGZa; anti-CDI 1 b 44 mAb or anti-BMMI mAbs). In lanes 
1-4, the Ag shown were ”sham-treated” under the conditions of 
N-glycanase digestion described in Fig. 2 prior to SDS-PAGE. 
Numbers on left represent the m.w. of protein standards: BSA, 
69400; ovalbumin, 46000; and carbonic anhydrase, 30000. 
Similar results were obtained in 3 other experiments. NO specific 
bands of a higher or lower m.w. than what is shown were 
observed. 
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Figure 2. SDS-PAGE analysis of glycosidase sensitivity of Mo5 
Ag immunoprecipitated from prccleared NP-40 lysates of radio- 
iodinated U-937 cells (U) and FMLP-stimulated PMNs (P) 
under reducing conditions. After immunoprecipitation. ”’I- 
labeled MoS Ag was eluted from the immunoconjugate and 
subjected to glycosidase treatment overnight a 37°C with N- 
glycanax (N-linked carbohydrate), lanes 3. 4; Endo-H (high- 
mannose), lanes 5, 6; neuraminidase (sialic acid), lanes 7, 8; 
and neuraminidase/ 0-glycanax (0-linked carbohydrate), lanes 
9, 10, versus sham treatment, lanes I ,  2. Neuraminidase treat- 
ments, alone or preceding 0-glycanase digestion, were per- 
formed at 37°C for I h. Digestions were performed in parallel 
with immunoprecipitates from isotype-identical control immun- 
oconjugates which were devoid of radiolabeled material in the 
relevant m.w. range for Mo5 (not shown). Results shown are 
a composite of six separate gels in which enzyme-treated Ag 
were run in parallel with sham-treated Ag (under identical 
conditions) on the same gel in adjacent lanes allowing reliable 
detection of small differences in apparent m.w. For simplicity, 
only two (of six) representative sham-treated controls are shown 
under conditions of neuraminidase/O-glycanase digestion. 
Similar results were obtained in two additional experiments for 
each cell type. 
shown in Fig. 2, Mo5 is a highly glycosylated mol- 
ecule comprised of predominantly N-linked com- 
plex carbohydrate as reflected by a nearly 40% 
reduction in apparent m.w. of the immunoprecip- 
itated Ag from both cell types (Fig. 2; lanes 3, 4) 
after treatment with N-Glycanase, which cleaves 
nearly all N-linked oligosaccharides between the 
asparagine and terminal carbohydrate residues 
(18). Despite the apparent heterogeneity of native 
PMN-derived Ag, only a single homogeneous band 
was observed after N-Glycanase digestion (ident- 
ical to the m.w. of N-Glycanase-digested U-937 
Ag). Digestion with Endo-H, which cleaves high- 
mannose and some hybrid, but not complex N- 
linked oligosaccharides (19), resulted in an ap- 
proximate 3 kD reduction in apparent m.w. (Fig. 
2; lanes 5 ,  6 compared to ‘sham’ lanes 1, 2). This 
is consistent with the presence of a relatively small 
component of high-mannose or hybrid asparagine- 
linked structures in the surface glycoprotein. Neur- 
aminidase treatment reduced the apparent m.w. of 
Mo5 by 1-3 kD, indicating the presence of sialic 
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Figure 3. Pulse-chase analysis of ”S-methionifle-labeled Mo5 
Ag from U-937 cells (U) and FMLP-stimulated PMNs (P) by 
SDS-PAGE under reducing conditions. U-937 cells (lanes 1-4) 
and FMLP-stimulated PMNs (lanes 5-8) were pulse-labeled for 
15 min in medium containing 15S-methionine, and then ‘chased’ 
with medium containing an excess of cold methionine for the 
times indicated prior to NP-40 cell lysis and immunopnxipita- 
tion. Arrows and brackets indicate the electrophoretic mobility 
of the precursor and mature form, respectively. In U-937 lanes, 
faint bands of approximately 47 kD were present in all immuno- 
precipitates, including isotype-identical controls (not shown), 
consistent with non-specific background. Similarly, bands of 
approximately 35 kD were present in all PMN lanes, including 
isotypc-identical control immunoprecipitates (not shown). con- 
sistent with non-specific background. Lanes 7 and 8 were con- 
trast-enhanced for purposes of reproduction. Similar results 
were obtained in two additional experiments for each cell type. 
acid on carbohydrate branches (Fig. 2; lanes 7, S), 
but subsequent 0-Glycanase digestion of neur- 
aminidase-treated Ag produced no further reduc- 
tion in the m.w. of Mo5 (Fig. 2; lanes 9, lo), 
suggesting there are no 0-linked oligosaccharides 
on the surface molecule. 
The biosynthesis of Mo5 in two cell types was 
examined by ’?3 pulse-chase experiments. U-937 
cells and FMLP-stimulated PMNs were pulse- 
labeled for 15 min in medium containing 3sS-meth- 
ionine, and then ‘chased’ with medium containing 
an excess of ‘cold’ methionine for the times indi- 
cated prior to NP-40 cell lysis and immunoprecipit- 
ation (20) (Fig. 3). In U-937 cells, analysis by SDS- 
PAGE revealed a single band of 41 kD at 0 min. 
By 30-60 min, a broader band of 47-55 kd was 
apparent in addition to the 41 kD component. By 
4 h, the 41 kD ‘precursor’ molecule was superseded 
by the broader 47-55 kD band (Fig. 3; lanes 1 4 ) ,  
approximating the electrophoretic mobility of the 
‘mature’ surface-labeled glycoprotein. Similarly, in 
PMNs, MoS appeared initially as a 43 kD band at 
0 min. By 1 hour, a second broader band of 46-52 
kD was seen which, by 4 h (Fig. 3; lanes 5-8), 
superseded the ‘precursor’ band, reflecting the ‘ma- 
ture’ form of the surface glycoprotein (Fig. 1; lane 
3 vs. Fig. 3; lane 8). Early glycosylation events 
concurrent with polypeptide synthesis (19) would 
account for the - 10 kD difference in m.w. between 
the N-Glycanase-treated surface Ag and the intern- 
ally-labeled precursor form. No immunoprecip 
itated Ag was detected in lysates of biosynthetically 
labeled, tunicamycin-treated cells (data not 
shown). Our inability to demonstrate immunoprec- 
ipitable Ag after cells were incubated in the pres- 
ence of tunicamycin, which selectively blocks the 
initiation of N-linked glycosylation (data not 
shown), may suggest either that the Mo5 antigenic 
epitope is in fact an oligosaccharide or that it is 
rapidly degraded under conditions which prevent 
N-linked glycosylation. Although surface ex- 
pression of Mo5 on PMNs is immediately up- 
modulated several fold by exposure to FMLP, pre- 
sumably as a consequence of its expression by 
granular membranes, FMLP had no discernible 
effect on the biosynthesis of Mo5 at 0 min or 4 h 
in stimulated PMNs as compared to unstimulated 
cells (data not shown). 
To examine the possibility that Mo5 is among 
the varied group of surface macromolecules linked 
to the plasma membrane via glycosyl-phosphati- 
dylinositol (GPI) (2 l), we analyzed surface ex- 
pression of Mo5 on PMNs before and after ex- 
posure to PI- PLC via indirect immunofluorescence 
analysis (17). No change in Mo5 surface expression 
as detected by anti-Mo5 mAb binding was seen, 
in contrast to the marked reduction of a PI-PLC 
sensitive antigen, CD16, under the same conditions 
(data not shown). 
Of particular interest is the finding that Mo5 is 
one of but a few glycoproteins which have been 
shown to be actively synthesized by the mature, 
differentiated PMN, traditionally thought to be 
metabolically inactive, incapable of significant de 
now protein synthesis (22). Recent efforts to assess 
the synthetic activity of the neutrophil have estab- 
lished that the mature blood PMN retains the abil- 
ity to synthesize, de n o w ,  a broad spectrum of 
macromolecules such as the cytokines IL-1 (23), 
IL-6 (24), IL-8 (25), G-CSF (26), M-CSF (26), and 
IFNa (27); certain extracellular matrix proteins 
such as fibronectin and thrombospondin (28); and 
the protease inhibitor, alpha 1-antiproteinase (ul- 
PI) (29). Mo5 can be distinguished as a novel ad- 
dition to this select group of macromolecules on 
the basis of its distinct m.w. of 50 kD, or, in the 
case of al-PI (also 50 kD), by its membrane localiz- 
ation (no surface staining by anti-al-PI [data not 
shown]). 
Likewise, whereas Mo5 shares certain character- 
istics with other previously identified myeloid sur- 
face markers including its relative lineage speci- 
ficity (30), up-modulation of surface expression on 
PMNs after exposure to soluble activating stimuli 
(3 I), and down-modulation caused by exposure to 
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’ As defined by the Fourth International WDrkshop and Conference on Human Leukocyte Dierentiation Antigens (30). 
’ Sensitivity to PI-PLC. 
‘Upmodulation’ defined here as a rapid (within minutes) increase in surface expression after exposure of PMNs or monocytes to soluble activating stimuli 
(e.g.. FMLP, PMA). 
‘ The major Source for the data shown is Leukocyte Typing IV - White Cell Differentiation Antigens (30). Citations indicate supplementary reterences. 
’ Abbreviations used: CFU-GM: colony forming unit-granulocyte, macrophages; M: monocyle; PMN: pobmorphonuclear neutrophil; LGL: large granular lymphocyte 
(natural killer cell); MB: macrophage; P: phtelet 8: B cell; E: eosinophil: UK: unknown; PI: phosphatldylinositot NA: not applicable; cell designation in 
parentheses ( ) indicates weak expression. 
’ PMN only (transmembrane form on M. LGL). 
a CD16 on PMNs is upmodubted by puritication procedures (31); subsequent exposure of PMNs to soluble activating stimuli results in release or shedding 
of surface Ag (33). 
that distinguish it from other antigens recognized 
by the Fourth International Workshop on Human 
Leukocyte Differentiation Antigens (30). as seen 
in Table I. 
The specific function of the Mo5 plasma mem- 
brane glycoprotein remains to be elucidated. Since 
anti-Mo5 mAb has no inhibitory effect on neutro- 
phi1 phagocytosis (34), enzyme release (34), aggre- 
gation (35), chemotaxis (l), or neutrophil-mediated 
tissue injury (36), the possibility exists that the 
epitope recognized by this reagent is functionally 
inert. Current efforts to raise a polyclonal antibody 
against affinity-purified Mo5 antigen may allow a 
better opportunity to screen for functional block- 
ing activity. The results of recent preliminary ex- 
periments employing anti-Mo5 mAb (in the form 
of F[ab], fragments) do, however, suggest the possi- 
bility that Mo5 has receptor-like activity: PMNs 
exposed to anti-Mo5 F[ab], fragments demonstrate 
a specific, transient increase in intracellular cal- 
cium, which, as observed for other receptors, may 
be analogous to the effect of natural ligand in 
generating calcium transients and other second 
messengers (37). 
In summary, Mo5 is a novel 50 kD glycosyla- 
ted surface macromolecule unique to human my- 
elomonocytic cells comprised of approximately 
40% complex carbohydrate. It is synthetized in 
both U-937 cells and PMNs as a 41-43 kD pre- 
cursor which is converted to the ‘mature’ 50 kD 
glycoprotein within 1 4  h. On comparison of its 
profile of lineage specificity, apparent molecular 
weight and carbohydrate composition, membrane 
linkage and modulated surface expression, it is 
unique among presently defined myelomonocytic 
differentiation antigens (30). Efforts are 
underway to elucidate the function of this mol- 
ecule and to isolate the Mo5 gene utilizing ex- 
pression cloning techniques. 
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